SAB Biotherapeutics, Inc. — Form D

SAB Biotherapeutics, Inc. of Miami Beach, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-16. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Scott J GibersonDirectorSioux Falls, SD
Christine J HamiltonDirectorSioux Falls, SD
David Charles LinkDirectorSioux Falls, SD
Erick Charles LuceraDirectorSioux Falls, SD
Andrew G MoinDirectorSioux Falls, SD
William Charles PolvinoDirectorSioux Falls, SD
SAMUEL J REICHDirectorMIAMI BEACH, FL
Jeffrey G SpragensDirectorSioux Falls, SD
Eddie J SullivanDirectorSioux Falls, SD
Russell J BeyerExecutive OfficerSioux Falls, SD
SAMUEL J REICHExecutive OfficerMIAMI BEACH, FL
Eddie J SullivanExecutive OfficerSioux Falls, SD
Andrew MoinDirectorMiami Beach, FL
Jay SkylerDirectorMiami Beach, FL
Erick LuceraDirectorMiami Beach, FL
Samuel ReichDirectorMiami Beach, FL
Samuel ReichExecutive OfficerMiami Beach, FL
William PolvinoDirectorMiami Beach, FL
Katie ElliasDirectorMiami Beach, FL
Eddie SullivanDirectorMiami Beach, FL
Eddie SullivanExecutive OfficerMiami Beach, FL
Jeffrey SpragensDirectorMiami Beach, FL
David LinkDirectorMiami Beach, FL
Scott GibersonDirectorMiami Beach, FL
Christine HamiltonDirectorMiami Beach, FL

Other filings by this issuer (1)

FiledFormOfferingSold
2025-08-05D$175.0M$175.0M

More